Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Compact designer TALENs for efficient genome engineering.

Beurdeley M, Bietz F, Li J, Thomas S, Stoddard T, Juillerat A, Zhang F, Voytas DF, Duchateau P, Silva GH.

Nat Commun. 2013;4:1762. doi: 10.1038/ncomms2782.

2.

A single-chain TALEN architecture for genome engineering.

Sun N, Zhao H.

Mol Biosyst. 2014 Mar 4;10(3):446-53. doi: 10.1039/c3mb70412b. Epub 2013 Dec 16.

PMID:
24336919
3.

[TALE nuclease engineering and targeted genome modification].

Shen Y, Xiao A, Huang P, Wang WY, Zhu ZY, Zhang B.

Yi Chuan. 2013 Apr;35(4):395-409. Review. Chinese.

PMID:
23659930
4.

Efficient targeted gene disruption in Xenopus embryos using engineered transcription activator-like effector nucleases (TALENs).

Lei Y, Guo X, Liu Y, Cao Y, Deng Y, Chen X, Cheng CH, Dawid IB, Chen Y, Zhao H.

Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17484-9. doi: 10.1073/pnas.1215421109. Epub 2012 Oct 8.

5.

Transcription activator-like effector nucleases (TALENs): a highly efficient and versatile tool for genome editing.

Sun N, Zhao H.

Biotechnol Bioeng. 2013 Jul;110(7):1811-21. doi: 10.1002/bit.24890. Epub 2013 Apr 7. Review.

PMID:
23508559
6.

Rapid and highly efficient construction of TALE-based transcriptional regulators and nucleases for genome modification.

Li L, Piatek MJ, Atef A, Piatek A, Wibowo A, Fang X, Sabir JS, Zhu JK, Mahfouz MM.

Plant Mol Biol. 2012 Mar;78(4-5):407-16. doi: 10.1007/s11103-012-9875-4. Epub 2012 Jan 22.

7.

Exploring the transcription activator-like effectors scaffold versatility to expand the toolbox of designer nucleases.

Juillerat A, Beurdeley M, Valton J, Thomas S, Dubois G, Zaslavskiy M, Mikolajczak J, Bietz F, Silva GH, Duclert A, Daboussi F, Duchateau P.

BMC Mol Biol. 2014 Jul 5;15:13. doi: 10.1186/1471-2199-15-13.

8.

Monomeric site-specific nucleases for genome editing.

Kleinstiver BP, Wolfs JM, Kolaczyk T, Roberts AK, Hu SX, Edgell DR.

Proc Natl Acad Sci U S A. 2012 May 22;109(21):8061-6. doi: 10.1073/pnas.1117984109. Epub 2012 May 7.

9.

EENdb: a database and knowledge base of ZFNs and TALENs for endonuclease engineering.

Xiao A, Wu Y, Yang Z, Hu Y, Wang W, Zhang Y, Kong L, Gao G, Zhu Z, Lin S, Zhang B.

Nucleic Acids Res. 2013 Jan;41(Database issue):D415-22. doi: 10.1093/nar/gks1144. Epub 2012 Nov 29.

10.

The I-TevI nuclease and linker domains contribute to the specificity of monomeric TALENs.

Kleinstiver BP, Wang L, Wolfs JM, Kolaczyk T, McDowell B, Wang X, Schild-Poulter C, Bogdanove AJ, Edgell DR.

G3 (Bethesda). 2014 Apr 16;4(6):1155-65. doi: 10.1534/g3.114.011445.

11.

Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease.

Sun N, Liang J, Abil Z, Zhao H.

Mol Biosyst. 2012 Apr;8(4):1255-63. doi: 10.1039/c2mb05461b. Epub 2012 Feb 3.

PMID:
22301904
12.

TALE nucleases: tailored genome engineering made easy.

Mussolino C, Cathomen T.

Curr Opin Biotechnol. 2012 Oct;23(5):644-50. doi: 10.1016/j.copbio.2012.01.013. Epub 2012 Feb 17. Review.

PMID:
22342754
13.

TAL effector nuclease (TALEN) engineering.

Li T, Yang B.

Methods Mol Biol. 2013;978:63-72. doi: 10.1007/978-1-62703-293-3_5.

PMID:
23423889
14.

Highly efficient and specific genome editing in silkworm using custom TALENs.

Ma S, Zhang S, Wang F, Liu Y, Liu Y, Xu H, Liu C, Lin Y, Zhao P, Xia Q.

PLoS One. 2012;7(9):e45035. doi: 10.1371/journal.pone.0045035. Epub 2012 Sep 18.

15.

Comprehensive analysis of the specificity of transcription activator-like effector nucleases.

Juillerat A, Dubois G, Valton J, Thomas S, Stella S, Maréchal A, Langevin S, Benomari N, Bertonati C, Silva GH, Daboussi F, Epinat JC, Montoya G, Duclert A, Duchateau P.

Nucleic Acids Res. 2014 Apr;42(8):5390-402. doi: 10.1093/nar/gku155. Epub 2014 Feb 24.

16.

Transcription activator-like effector nucleases enable efficient plant genome engineering.

Zhang Y, Zhang F, Li X, Baller JA, Qi Y, Starker CG, Bogdanove AJ, Voytas DF.

Plant Physiol. 2013 Jan;161(1):20-7. doi: 10.1104/pp.112.205179. Epub 2012 Nov 2.

17.

megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering.

Boissel S, Jarjour J, Astrakhan A, Adey A, Gouble A, Duchateau P, Shendure J, Stoddard BL, Certo MT, Baker D, Scharenberg AM.

Nucleic Acids Res. 2014 Feb;42(4):2591-601. doi: 10.1093/nar/gkt1224. Epub 2013 Nov 26.

18.

Designing and testing the activities of TAL effector nucleases.

Lin Y, Cradick TJ, Bao G.

Methods Mol Biol. 2014;1114:203-19. doi: 10.1007/978-1-62703-761-7_13.

PMID:
24557905
19.

Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting.

Cermak T, Doyle EL, Christian M, Wang L, Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ, Voytas DF.

Nucleic Acids Res. 2011 Jul;39(12):e82. doi: 10.1093/nar/gkr218. Epub 2011 Apr 14. Erratum in: Nucleic Acids Res. 2011 Sep 1;39(17):7879.

20.

Transcription activator-like effector nucleases mediated metabolic engineering for enhanced fatty acids production in Saccharomyces cerevisiae.

Aouida M, Li L, Mahjoub A, Alshareef S, Ali Z, Piatek A, Mahfouz MM.

J Biosci Bioeng. 2015 Oct;120(4):364-71. doi: 10.1016/j.jbiosc.2015.02.017. Epub 2015 Apr 20.

PMID:
25907574

Supplemental Content

Support Center